Iovance Biotherapeutics, Inc.

Iovance Biotherapeutics is a leading immunotherapy company focused on developing and delivering tumor infiltrating lymphocyte (TIL) therapy for patients with cancer. They are pioneering a transformational approach to cancer treatment by harnessing the power of the human immune system to recognize and attack diverse cancer cells in each patient. Their investigational TIL therapy has shown promising clinical data across multiple solid tumors, including melanoma, non-small cell lung cancer, and cervical cancer.

Iovance is committed to continuous innovation in cell therapy, including gene-edited cell therapy, and is also investigating a peripheral blood lymphocyte (PBL) therapy platform for blood cancers. The company has a robust pipeline of clinical trials and is actively seeking partnerships to further develop their products. Iovance is headquartered in San Carlos, California, and has a state-of-the-art manufacturing facility in Philadelphia, Pennsylvania.

Iovance Biotherapeutics offers a flexible work environment, providing employees with a stipend for technology and remote work. The company also offers a robust benefits package including competitive salaries, annual cash bonuses, and long-term incentives. Additionally, employees have access to professional development opportunities, including tuition assistance, and a variety of health and wellness programs.

Iovance Biotherapeutics offers a comprehensive benefits package to its employees, encompassing health and wellness, total rewards, and professional development opportunities. These benefits include flexible medical plans with low or no employee cost, company contributions to Health Savings Accounts, comprehensive dental and vision coverage, flexible spending and Health Savings Accounts, paid holidays and vacation and sick time, paid parental leave, an Employee Assistance Program, and a wellness program with discounts for gym memberships and other activities. Additionally, the company provides competitive salaries, annual cash bonuses, long-term incentives, a 401(k) plan with a match, income protection plans, voluntary life insurance, an Employee Stock Purchase Plan, and tuition assistance.

Iovance Biotherapeutics aims to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) therapy for people with cancer. They are pioneering a transformational approach to treating cancer by harnessing the ability of the human immune system to recognize and attack diverse cancer cells in each patient. They are committed to continuous innovation in cell therapy, including gene-edited cell therapy, to extend and improve life for people with cancer.

Iovance Biotherapeutics promotes a patient-centric, collaborative, and innovative culture. They emphasize high integrity and strive for excellence, acting with agility to create value for all stakeholders. They are committed to continuous innovation in cell therapy and fostering a positive, inclusive work environment.

Iovance Biotherapeutics is committed to fostering a diverse and inclusive work environment where all employees and applicants are treated equally, regardless of their race, color, religion, sex, pregnancy, national origin, age, physical and mental disability, marital status, sexual orientation, gender identity, gender expression, genetic information, military and veteran status, or any other characteristic protected by applicable law. They actively seek to create a welcoming and supportive environment where everyone feels valued, respected, and empowered to contribute their unique skills and perspectives.